NEW YORK (GenomeWeb News) – The National Institutes of Health issued a notice last week that it expects researchers working with cultured cells to use authentication procedures in order to avoid misidentified or contaminated cultures that can significantly affect research outcomes.
 
The NIH cautioned that grant applications that fail to employ authentication methods “would not be considered of the highest quality and such manuscripts would not fare well in the journal review process.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.